Arrhythmia Drugs Flashcards
(8 cards)
Amiodarone
MOA: Decrease sinus node and slows atrioventricular bypass tract conduction and prolong refractory period of myocardial tissues.
Indication: treatment and prophylaxis of serious tachyarrhythmias refractory to other treatment.
Side effect: worsen arrhythmia (very long half life), nausea vomiting, constipation
Counsel: Avoid sun exposure, wear protective clothing and use sunscreen.
Avoid grapefruit juice
Monitor blood test, ECG and chest x-ray
Digoxin
MOA: Inhibits Na+/K+ ATPase pump
- Causing an increase in intracellular calcium = increase cardiac contraction
- Improve CO leads to reduce sympathetic nerve activity = reduce HR
- Increase parasympathetic effect - slow down conduction velocity through the AV node
Indication: HF and AF
Precautions: hyper/hypothyrodisim and electrolyte imbalance and cardiac
Avoid using with drugs that slow cardiac conduction or inhibit/induce P-gp as it increase ADR or decrease efficacy.
Reduce dose in renal impairment
HALF the dose if CrCl = <60L/min
Disopyramide
Prolong refractory period of myocardial tissue and reduce automaticity in Purkinje fibres.
Indication: life threatening VT
Precaution
- Digoxin toxicity—contraindicated.
- Treatment with flecainide—contraindicated.
- Electrolyte disturbances (eg hypokalaemia, hyperkalaemia, hypomagnesaemia)—increase risk of arrhythmias; correct before starting treatment if possible.
ADR: May worsen arrhythmia, dry mouth, constipation, N/V
Lignocaine/Lidocaine
MOA: Reduces automaticity of myocardial tissue with little effect on cardiac conduction.
Flecainide
MOA: Slows cardiac conduction and to a lesser extent, increases refractory period in all myocardial tissues (including bypass tracts) but particularly in the His-Purkinje (ventricular conduction) system. Also has negative inotropic activity.
May worsen arrhythmia
Adenosine
MOA: Depresses sinus node activity and slows conduction through the atrioventricular node; also produces peripheral and coronary vasodilation.
Adenosine has a rapid onset and short duration of action.
Atropine
MOA: short acting muscarinic antagonist increase HR by inhibiting parasympathetic system causing an activation of sympathetic system
Isoprenaline
MOA: Beta agonist, increase cardiac output, tend to maintain or increase systolic BP and decrease diastolic BP by lowering SVR. It increases automaticity and AVN conduction improving coronary blood flow